Hunan Oula Medical Technology Co., Ltd.

A single-center, randomized, open, two-period, self-crossover, single-dose administration design was used to conduct a fasting and postprandial administration trial to evaluate the bioequivalence and safety of acetylcysteine granules (acetylcysteine, specification: 0.2 g) produced by Hunan Oula Pharmaceutical Technology Co., Ltd. and Hunan Xinhui Pharmaceutical Co., Ltd. and acetylcysteine granules (acetylcysteine, trade name: Fulushi®, specification: 0.2 g) produced by Hainan Zanbang Pharmaceutical Co., Ltd. after oral administration of the two preparations in fasting and postprandial states in healthy Chinese subjects, so as to provide a basis for the registration application of the test preparation.